Vivimed Labs Limited — Board Meeting, 31-05-2025: Outcome of Board Meeting

Vivimed Labs has announced a board meeting approving the audited financial results for the year ended March 31, 2025. Consolidated revenue was Rs 120.67 Cr, down from Rs 149.07 Cr last year. The company narrowed its consolidated net loss to Rs 31.96 Cr from Rs 45.45 Cr previously. Operating costs remain high, with borrowings of Rs 374.46 Cr classified as NPA and significant interest expenses yet to be recognized due to lender talks. Management plans to sustain operations through cost reductions and debt restructuring amid ongoing challenges.